American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Dahi
    Dahi
  4. Devlin
    Devlin
  5. Ponce
    Ponce
  6. Tamari
    Tamari
  7. Papadopoulos
    Papadopoulos
  8. Shah
    Shah
  9. Jakubowski
    Jakubowski
  10. Scordo
    Scordo

Groups

  1. MSK Grad Students (298)
  2. Center for Hematologic Malignancies (279)
  3. Department of Medicine (265)
  4. Hematologic Malignancies, Division of (264)
  5. CTCR Scholars (207)
  6. Master of Science in Clinical and Translational Cancer Research (199)
  7. Bone Marrow Transplant (193)
  8. GSK Faculty (159)
  9. Survivorship Research (156)
  10. Sloan Kettering Institute Postdocs (120)
Search Within
  1. "MSK Grad Students"
Formats
  1. Meeting Abstract (235)
  2. Journal Article (61)
  3. Research Letter (2)
Groups
  1. MSK Grad Students (298)
  2. Center for Hematologic Malignancies (279)
  3. Department of Medicine (265)
  4. Hematologic Malignancies, Division of (264)
  5. CTCR Scholars (207)
  6. Master of Science in Clinical and Translational Cancer Research (199)

More Groups

People
  1. Sergio Giralt (126)
  2. Miguel-Angel Perales (113)
  3. Parastoo Dahi (89)
  4. Sean Devlin (88)
  5. Doris Ponce (81)
  6. Craig Sauter (71)

More People

Years
  1. 2024 (1)
  2. 2023 (33)
  3. 2022 (31)
  4. 2021 (34)
  5. 2020 (34)
  6. 2019 (30)

More Years

Publications
  1. Blood (263)
  2. Blood Advances (34)
  3. Hematology-American Society of Hematology Education Program (1)

Results (298)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
    Journal Article

    Dao, T.; Xiong, G.; Mun, S. S.; Meyerberg, J.; Korontsvit, T.; Xiang, J.; Cui, Z.; Chang, A. Y.; Jarvis, C.; Cai, W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The composite health risk assessment model (CHARM) to predict 1-year non-relapse mortality (NRM) among older recipients of allogeneic transplantation: A prospective BMT-CTN study 1704
    Meeting Abstract

    Artz, A.; Logan, B. R.; Saber, W.; Geller, N.; Bellach, A.; Kou, J.; Wood, W.; McCarty, J. M.; Knight, T. G.; Runaas, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular taxonomy of myelodysplastic syndromes and its clinical implications
    Meeting Abstract

    Bernard, E.; Hasserjian, R.; Greenberg, P. L.; Ossa, J. E. A.; Creignou, M.; Nannya, Y.; Tuechler, H.; Medina-Martínez, J. S.; Levine, M. F.; Jädersten, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, shows rapid primary engraftment with CD33-negative hematopoiesis in patients with high-risk acute myeloid leukemia (AML) and avoids hematopoietic toxicity during gemtuzumab ozogamicin (GO) maintenance post-hematopoietic cell transplant (HCT)
    Meeting Abstract

    DiPersio, J.; Cooper, B. W.; Suh, H. C.; Koura, D.; Bernard, L.; Shah, N. N.; Walter, R. B.; Perales, M. A.; Mapara, M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A personalized whole genome-informed assay targeting single mutant in circulating tumor DNA can identify MRD and predict relapse in DLBCL
    Meeting Abstract

    Merryman, R. W.; Rhoades, J.; Xiong, K.; Antel, K.; An, H. H.; Redd, R. A.; McDonough, M. M.; Guerrero, L.; Crnjac, A.; Sridhar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Updated findings of a phase II study of ruxolitinib pre-, during- and post-hematopoietic stem cell transplantation for patients with primary or secondary myelofibrosis
    Meeting Abstract

    Hobbs, G. S.; Kim, H. T.; O'Connor, S.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; El-Jawahri, A.; McAfee, S.; Hem, J.; Lozano, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • UBA1 mutations identify a rare but distinct subtype of myelodysplastic syndromes
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Creignou, M.; Domenico, D.; Farina, A.; Ossa, J. E. A.; Kosmider, O.; Hasserjian, R.; Jädersten, M.; Germing, U.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • m (6)A-SON-CCL5 axis controls HSC fate and inflammation
    Meeting Abstract

    Luo, H.; Cortés-López, M.; Tam, C. L.; Xiao, M.; Wakiro, I.; Chu, K. L.; Pierson, A.; Chan, M.; Chang, K.; Yang, X.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of investigational microbiome therapeutic SER-155 on pathogen domination: Initial results from a phase 1b study in adults undergoing allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Peled, J. U.; van den Brink, M. R. M.; Ponce, D. M.; Kosuri, S.; Khera, N.; DeFilipp, Z.; Tejura, B.; Lichter, D. I.; Lombardo, M. J.; Wortman, J. R.; more...
    Blood (2023)

    Fulltext@MSK | Save